Search Results - "Cobb, Carla"
-
1
Board-Certified Psychiatric Pharmacists and Their Potential Role in Addressing Behavioral Health Workforce Shortages
Published in Psychiatric services (Washington, D.C.) (01-10-2024)“…Board-certified psychiatric pharmacists (BCPPs) are doctorate-level, board-certified experts in managing medications for people living with psychiatric…”
Get full text
Journal Article -
2
Optimizing Medication Use with a Pharmacist-Provided Comprehensive Medication Management Service for Patients with Psychiatric Disorders
Published in Pharmacotherapy (01-12-2014)“…Our objective was to evaluate a pharmacist‐delivered comprehensive medication management (CMM) service provided to patients with psychiatric disorders. We…”
Get full text
Journal Article -
3
Systematic literature review of the impact of psychiatric pharmacists
Published in The mental health clinician (01-02-2024)“…Pharmacists focusing on psychotropic medication management and practicing across a wide variety of healthcare settings have significantly improved…”
Get full text
Journal Article -
4
Social Determinants of Health in People Living with Psychiatric Disorders: The Role of Pharmacists
Published in Health equity (01-04-2023)“…Social determinants of health (SDOH) affect outcomes of people living with psychiatric disorders, including substance use disorders. As experts in medication…”
Get full text
Journal Article -
5
Survey of prescriptive authority among psychiatric pharmacists in the United States
Published in The mental health clinician (01-03-2021)“…Despite the high prevalence of those with mental illnesses, there is a critical shortage of psychiatric providers in the United States. Psychiatric pharmacists…”
Get full text
Journal Article -
6
Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements
Published in The mental health clinician (01-04-2022)“…A 2019 survey identified significant variability of practice characteristics among outpatient psychiatric pharmacists (OPPs). No published model establishes…”
Get full text
Journal Article -
7
Assessment of the current practice of psychiatric pharmacists in the United States
Published in The mental health clinician (01-11-2020)“…A comprehensive review of psychiatric pharmacy practice has never been performed in the United States. As psychiatric pharmacists become more involved in…”
Get full text
Journal Article -
8
Psychiatric pharmacist integration into the medical home
Published in Primary care companion for CNS disorders (2013)Get full text
Journal Article -
9
Comprehensive medication management for patients with mental illnesses
Published in The mental health clinician (01-10-2013)“…Comprehensive medication management (CMM) is a patient-care practice that aims to ensure that a patient's medication therapy is effective and safe. This…”
Get full text
Journal Article -
10
Development of the Core Outcome Set for Psychiatric Pharmacists
Published in JAACP : Journal of the American College of Clinical Pharmacy (01-02-2024)“…Objective The American Association of Psychiatric Pharmacists (AAPP) sought to develop a consensus‐based set of outcomes and measures to standardize…”
Get full text
Journal Article -
11
Impact of pharmacists on outcomes for patients with psychiatric or neurologic disorders
Published in The mental health clinician (01-11-2020)“…Psychiatric and neurologic illnesses are highly prevalent and are often suboptimally treated. A 2015 review highlighted the value of psychiatric pharmacists in…”
Get full text
Journal Article -
12
Duloexetine (Cymbalta) for treatment of major depressive disorder
Published in American family physician (15-09-2005)Get full text
Journal Article -
13
Psychiatric Pharmacist Integration Into the Medical Home: Commentary
Published in Primary care companion for CNS disorders (22-08-2013)Get full text
Journal Article -
14
Three MTM success stories
Published in The mental health clinician (01-08-2011)Get full text
Journal Article -
15
Our vision for the future
Published in The mental health clinician (01-10-2011)Get full text
Journal Article -
16
Duloxetine (Cymbalta) for Treatment of Major Depressive Disorder
Published in American family physician (15-09-2005)“…Duloxexetine is a serotonin and norepinephrine reuptake inhibitor in the same class as venlafaxine. It is approved by the US Food and Drug Administration for…”
Get full text
Journal Article